- Home
- OBIO vs STG Comparison
OBIO vs STG Comparison
Compare OBIO & STG Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- OBIO
- STG
- Stock Information
- Founded
- OBIO 2017
- STG 2003
- Country
- OBIO United States
- STG China
- Employees
- OBIO N/A
- STG N/A
- Industry
- OBIO Medicinal Chemicals and Botanical Products
- STG Other Consumer Services
- Sector
- OBIO Health Care
- STG Real Estate
- Exchange
- OBIO Nasdaq
- STG Nasdaq
- Market Cap
- OBIO 146.2M
- STG 118.9M
- IPO Year
- OBIO N/A
- STG 2018
- Fundamental
- Price
- OBIO $2.74
- STG $8.25
- Analyst Decision
- OBIO Strong Buy
- STG
- Analyst Count
- OBIO 4
- STG 0
- Target Price
- OBIO $14.00
- STG N/A
- AVG Volume (30 Days)
- OBIO 227.6K
- STG 8.7K
- Earning Date
- OBIO 11-11-2025
- STG 11-21-2025
- Dividend Yield
- OBIO N/A
- STG N/A
- EPS Growth
- OBIO N/A
- STG N/A
- EPS
- OBIO N/A
- STG 3.59
- Revenue
- OBIO $2,944,000.00
- STG $279,374,215.00
- Revenue This Year
- OBIO $29.26
- STG N/A
- Revenue Next Year
- OBIO $10.65
- STG N/A
- P/E Ratio
- OBIO N/A
- STG $2.29
- Revenue Growth
- OBIO 41.61
- STG N/A
- 52 Week Low
- OBIO $2.20
- STG $4.28
- 52 Week High
- OBIO $6.50
- STG $15.00
- Technical
- Relative Strength Index (RSI)
- OBIO 59.98
- STG 45.77
- Support Level
- OBIO $2.20
- STG $8.00
- Resistance Level
- OBIO $2.89
- STG $8.50
- Average True Range (ATR)
- OBIO 0.14
- STG 0.54
- MACD
- OBIO 0.04
- STG 0.04
- Stochastic Oscillator
- OBIO 78.26
- STG 79.32
About OBIO Orchestra BioMed Holdings Inc.
Orchestra BioMed Holdings Inc is a biomedical innovation company accelerating high-impact technologies to patients through risk-reward sharing partnerships. Its partnership-enabled business model focuses on forging strategic collaborations with medical device companies to drive the commercialization of the products it develops. The company's flagship product candidates include BackBeat Cardiac Neuromodulation Therapy (CNT) for the treatment of hypertension and Virtue Sirolimus AngioInfusionBalloon (SAB) for the treatment of atherosclerotic artery disease.
About STG Sunlands Technology Group
Sunlands Technology Group is a provider of online post-secondary and professional education services in China. The company offers various degree- and diploma-oriented post-secondary courses through its online platforms. In addition, it provides online professional courses and educational content to help students prepare for professional certification exams and attain professional skills. The Group has one operating segment, which is the provision of online education services.